Targeting Galectin-3 in Inflammatory and Fibrotic Diseases

Galectin (Gal)-3 is a β-galactoside-binding lectin emerging as a key player in cardiac, hepatic, renal, and pulmonary fibrosis and inflammation, respiratory infections caused by COVID-19, and neuroinflammatory disorders. Scientists review recent information highlighting Gal-3 as a relevant therapeutic target in these specific disease conditions.